We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+12.57%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$750M
AUM Growth
+$262M
Cap. Flow
+$205M
Cap. Flow %
27.3%
Top 10 Hldgs %
28.71%
Holding
137
New
15
Increased
36
Reduced
40
Closed
5

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$14.3M
2
ALGN icon
Align Technology
ALGN
+$13.8M
3
WBA
Walgreens Boots Alliance
WBA
+$13.5M
4
AMGN icon
Amgen
AMGN
+$12M
5
CNC icon
Centene
CNC
+$9.49M

Top Sells

Rank Stock Value
1
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$4.67M
2
SYK icon
Stryker
SYK
+$4.15M
3
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
+$1.91M
4
BDX icon
Becton Dickinson
BDX
+$1.79M
5
ZBH icon
Zimmer Biomet
ZBH
+$1.75M

Sector Composition

Rank Sector Weight
1 Healthcare 92.09%
2 Financials 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.05T
$11.1M 1.47%
131,400
+96,400
+275% +$7.72M
ZBH icon
27
Zimmer Biomet
ZBH
$17.6B
$10.7M 1.43%
90,640
-15,450
-15% -$1.75M
VTRS icon
28
Viatris
VTRS
$20.1B
$10M 1.34%
257,200
+21,500
+9% +$867K
BAX icon
29
Baxter International
BAX
$11.7B
$9.85M 1.31%
190,000
– –
DHR icon
30
Danaher
DHR
$144B
$9.75M 1.3%
128,592
+45,120
+54% +$3.36M
COR icon
31
Cencora
COR
$59.9B
$9.04M 1.2%
+102,099
New +$8.97M
WMGI
32
DELISTED
Wright Medical Group Inc
WMGI
$8.98M 1.2%
288,663
+278,663
+2,787% +$7.56M
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
$8.61M 1.15%
71,000
+21,600
+44% +$2.78M
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$123B
$8.31M 1.11%
76,000
-5,000
-6% -$440K
IONS icon
35
Ionis Pharmaceuticals
IONS
$8.99B
$8.25M 1.1%
205,253
+114,253
+126% +$5.13M
MNK
36
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$8.14M 1.09%
182,725
+101,925
+126% +$5.03M
ABMD
37
DELISTED
Abiomed Inc
ABMD
$7.97M 1.06%
63,670
+18,620
+41% +$2.16M
HZNP
38
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.37M 0.98%
498,765
+474,765
+1,978% +$7.69M
ALNY icon
39
Alnylam Pharmaceuticals
ALNY
$35.7B
$7.27M 0.97%
141,900
+117,900
+491% +$5.45M
HRC
40
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$7.22M 0.96%
+102,274
New +$6.51M
AGN
41
DELISTED
Allergan plc
AGN
$6.93M 0.92%
29,000
-400
-1% -$93.2K
ABBV icon
42
AbbVie
ABBV
$450B
$6.69M 0.89%
102,701
+87,701
+585% +$5.51M
PRGO icon
43
Perrigo
PRGO
$1.48B
$6.27M 0.84%
94,411
+65,411
+226% +$4.97M
ALR
44
DELISTED
Alere Inc
ALR
$5.78M 0.77%
145,363
+97,380
+203% +$3.8M
THC icon
45
Tenet Healthcare
THC
$16.8B
$5.77M 0.77%
+325,546
New +$6.04M
BMRN icon
46
BioMarin Pharmaceuticals
BMRN
$11.5B
$5.71M 0.76%
65,000
– –
MGNX icon
47
MacroGenics
MGNX
$285M
$5.67M 0.76%
304,597
+221,597
+267% +$4.27M
EGRX
48
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5.62M 0.75%
67,700
+27,000
+66% +$2.01M
BDX icon
49
Becton Dickinson
BDX
$43.6B
$5.5M 0.73%
30,750
-10,250
-25% -$1.79M
AET
50
DELISTED
Aetna Inc
AET
$5.43M 0.72%
42,600
+26,200
+160% +$3.29M
1
2
3 4 5

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q1 2017 Portfolio in Review

As of Q1 2017, Bellevue Group held 137 positions worth $750M, up 54% from $488M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bellevue Group deployed $205M of net new capital in Q1 2017, opening 15 new positions and adding to 36 existing holdings. Its largest new stake was Align Technology: 136,200 shares worth $15.6M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 92% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Stryker, an estimated $4.15M trimmed.

  • Bellevue Group's largest Q1 2017 buy was Align Technology: 136,200 shares worth $15.6M.
  • Bellevue Group added most to Elevance Health in Q1 2017, an estimated $14.3M increase.
  • Bellevue Group's biggest Q1 2017 reduction was Stryker, cutting an estimated $4.15M.
  • Bellevue Group fully exited Ariad Pharmaceuticals Inc in Q1 2017, selling an estimated $4.67M.
  • Bellevue Group's ten largest holdings make up 29% of its $750M portfolio in Q1 2017.
  • Bellevue Group opened 15 new positions and closed 5 in Q1 2017.
  • Bellevue Group's portfolio value rose 54% quarter-over-quarter to $750M.

Based on Bellevue Group's 13F filing for Q1 2017, filed 11 May 2017.